Mandatory Notification of Trade - Cecilie Grue
(Oslo, Norway, 27 September 2016) Reference is made to the announcement on 14 September 2016 by Bionor Pharma ASA ("Bionor" or the "Company", ticker "BIONOR") regarding the primary insider notification from certain primary insiders of the Company that have received Subscription Rights in the Rights Issue.
STOCK EXCHANGE ANNOUNCEMENT
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN, HONG KONG OR THE UNITED STATES
Primary insider notification – Cecilie Grue
Grue Invest AS a company wholly owned by Cecilie Grue, a primary insider of the Company, exercised 165,162 Subscription Rights in the Company on 26 September 2016, and following such transaction holds the following interests in the Company:
in the Rights Issue
Cecilie Grue through
|Director of legal affairs||270,762||0|
The subscription price for the shares is NOK 0.10 per share.
Unni Hjelmaas, Acting CEO, +47 915 19 651, firstname.lastname@example.org
Jens Krøis, CFO, +45 208 01 668, email@example.com
Link to announcement in pdf